Page 2 - Disclosure Topic News Today : Breaking News, Live Updates & Top Stories | Vimarsana

This is Part I of a two-part series outlining key considerations from White & Case's Public Company Advisory Group for US public companies during the 2022 annual reporting and proxy...

A New Year’s Resolution for U.S. Nuclear Utilities

To embed, copy and paste the code into your website or blog: On March 9, 2021, the Corporation Finance Division of the Securities and Exchange Commission (SEC) updated its guidance in Disclosure Topic No. 7 for preserving confidential treatment of exhibits redacted pursuant to an SEC confidential treatment order (CTO) that is about to expire. CTOs are becoming more rare. Most companies obtain confidential treatment without a CTO by filing redacted copies of the exhibits in accordance with Regulation S-K Item 601(b)(10)(iv), which allows companies to redact immaterial, competitively harmful i...

To embed, copy and paste the code into your website or blog: This is Part I of a two-part memorandum series outlining key considerations from White & Case’s Public Company Advisory Group for US public companies during the 2021 annual reporting and proxy season. Part I of this memo describes our key considerations for Annual Reports on Form 10-Ks in two parts: (1) Housekeeping Items for Form 10-Ks in 2021; and (2) Top Nine Disclosure Considerations for the Form 10-K in 2021. Part II of the series will describe key considerations for Annual Meeting Proxy Statements. Considerations for Annual ...